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Several lines of evidence suggest that certain subtypes of obsessive-compulsive and tic disorders 
might be pediatric manifestations of post-streptococcal autoimmunity caused by cross-reactive 
auto-antibodies. As tumor necrosis factor (TNF) is known to play a seminal role in coordinating 
the humoral immune response, TNF gene polymorphisms have been proposed as genetic risk 
factors both in obsessive-compulsive disorder (OCD) and Tourette syndrome (TS). The aim of 
present study was to investigate two TNF promoter polymorphisms (-238 A/G: rs361525 and -
308 A/G: rs1800629) on the genetic susceptibility to OCD and TS in a child psychiatric sample 
(102 OCD and 117 TS patients). In the case-control setup the genotype and allele frequencies 
were compared to a control group from the general population (n=405). As a control child 
psychiatric sample, 194 children with attention deficit hyperactivity disorder were also 
genotyped. Our results revealed that the TNF -308 G-allele was more frequent in children with 
TS compared to controls (90.2% vs 84.8%, p=0.037). For confirmation of this genetic association 
a family based analysis, the Transmission Disequilibrium Test was used, which showed 
preferential transmission of the G-allele to TS patients (nominal p-value 0.011). Moreover, this 
allele was also transmitted more frequently to children with tic symptoms (nominal p-value 
0.039). No association was found between OCD or obsessive, compulsive symptoms and the 
studied TNF polymorphisms. Based on these findings, the TNF -308 G-allele can be associated 
with Tourette syndrome, highlighting the potential pathophysiological role of TNF dysregulation. 
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Introduction 
Obsessive-compulsive disorder (OCD) affects approximately 2% of the child and adolescent 
population (Boileau, 2011). It is characterized by intrusive thoughts (obsessions) that are 
expected to be relieved by repetitive acts (compulsions). The obsessions and compulsions are 
time consuming, and significantly interfere with the person’s normal routine, occupational 
functioning, or social activities (American Psychiatric Association, 2013). In half of the cases the 
symptom onset is below age 19 (Kessler et al., 2005). Twin studies indicate the importance of 
separating childhood-onset OCD, because the observed genetic influence on OCD symptoms is 
much higher in children (ranging from 45% to 65%) compared to adults (where the heritability 
estimates are between 27-47%) (van Grootheest et al., 2005). Tourette syndrome (TS) is less 
frequent with a prevalence rate of 1% in school-age children. It is part of the tic-spectrum 
disorders, which affect 6-12% of children (Singer, 2005). TS is characterized by multiple motor 
tics and at least one phonic tic, and is rarely present without comorbid conditions, such as OCD 
and/or attention deficit hyperactivity disorder (ADHD) (Singer, 2005). As the involuntary 
movements and vocalizations in TS, the obsessions and compulsions in OCD, or the impulsivity 
in ADHD might reflect inhibitory control problems in the basal ganglia-thalamo-cortical circuits 
(as proposed by Casey et al., 2001), we aimed to study genetic risk factors in these three basal 
ganglia related neuropsychiatric disorders. 
The term PANDAS (pediatric autoimmune neuropsychiatric disorders associated with 
streptococcal infections) was coined by Swedo and co-workers (1998) to describe a subset of 
neuropsychiatric disorders that are suspected to be corollaries of streptococcal infections. This 
novel though debated neuropathological category encompasses some OCD and TS cases as well 
as other entities from the tic spectrum disorders, assigning a causative role to auto-reactive post-
streptococcal antibodies in the pathogenesis (Martino et al., 2009). Infections by group A beta-
hemolytic Streptococcus might cause immune dysregulation, resulting in the production of 
primarily anti-streptococcal anti-M antibodies that elicit various inflammatory diseases such as 
polyarthritis (acute rheumatic fever) aggravated by endocarditis. These antibodies can also cross-
react with certain epitopes in the central nervous system including glycolytic enzymes such as 
pyruvate kinase, aldolase C, and neuron-specific enolase (Dale et al., 2006). Structural and 
functional impairment of the basal ganglia and corpus striatum by these auto-antibodies might 
manifest either in Sydenham chorea (chorea minor) or PANDAS. On the other hand, little is 
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known on the pathomechanism of neuronal dysfunctions, albeit there are data indicating that self-
reactive antibodies detected in chorea minor (the cerebral manifestation of acute rheumatic fever) 
might induce the activation of calcium/calmodulin dependent protein kinase II (Kirvan et al., 
2003). Importantly, the tics - as involuntary movement symptoms - are present in the majority of 
PANDAS cases, indicating the impairment of basal ganglia in the pathogenesis.  
Production of self-reactive antibodies is probably due to an imbalance of pro-inflammatory 
cytokines including interleukin 1 and tumor necrosis factor (TNF) that govern the function of B 
lymphocytes in the humoral response (Alleva et al., 2000). TNF is released from activated 
monocytes, macrophages (microglia in the central nervous system), as well as T and B 
lymphocytes (Sarit et al., 2012) with profound biological activities including apoptosis induction, 
inflammation and insulin resistance. Furthermore, several studies found elevated plasma TNF 
and/or TNF receptor levels in OCD (Fontenelle et al., 2012; Konuk et al., 2007), although there 
is a report on decreased or unchanged cytokine levels as well (Denys et al., 2004). No significant 
alterations in TNF plasma levels have been revealed in TS yet (Gabbay et al., 2009). 
The TNF gene (previously known as TNF-alpha, OMIM ID: 191160) is localized to the 6p21.33 
locus in the neighborhood of several other TNF cluster genes. The gene spans about 3 kb and 
encompasses 4 exons. Several inducible transcription factors such as nuclear factor-κB and 
nuclear factor of activated T cells (NFAT) have been shown to be recruited to the TNF promoter 
conferring cell type-specific expression on the gene (Falvo et al., 2010). Genetic polymorphisms 
in the regulatory regions of the TNF gene have been reported to associate with a wide range of 
inflammatory, immunological, and malignant diseases. Dozens of single nucleotide 
polymorphisms (SNPs) have been identified to date that might influence plasma TNF levels via 
modulating its transcription and thereby enhance the susceptibility to the above mentioned 
illnesses (Qidwai & Khan, 2011). Among them, 2 SNPs have been implicated most frequently in 
disease pathology: the -238 A/G (rs361525) and the -308 A/G (rs1800629) polymorphisms. The 
assumption that TNF polymorphisms might associate with pediatric neuropsychiatric disorders 
mentioned above (OCD, TS, and ADHD) has already been addressed by a number of studies 
(Hounie et al., 2008; Liu et al., 2011; Drtilkova et al., 2008, respectively).  As TNF seems to be a 
likely candidate gene in post-streptococcal pediatric disorders, we aimed to analyze the genotype 
distribution of these two important TNF promoter SNPs in children affected by OCD or TS. To 
assess the specificity of TNF polymorphisms on the genetic susceptibility of OCD and TS, we 
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also included patients with ADHD, one of the most common basal ganglia related disorders in 
childhood.  
 
Materials and Methods 
The study was designed in compliance with the Helsinki Declaration and was approved by the 
Hungarian Scientific and Research Ethics Committee of the Medical Research Council (ETT-
TUKEB). The patients and their parents, as well as the healthy control subjects provided written 
informed consent to their participation. Both the clinical and the control samples were ethnically 
homogenous, of Caucasian origin. A total of 413 children were recruited at the Vadaskert Child 
and Adolescent Psychiatric Clinic with the major diagnoses of OCD, TS, or ADHD, according to 
DSM-IV criteria (for the description of the three patient groups see Table 1). The control group 
consisted of 405 healthy young adults (mean age: 21.26 ± 2.63 years, 51.1% male). Family data 
was accessible from 105 children (out of the 117 cases) diagnosed with TS. For the family based 
analyses of tic disorders 264 parents (from 114 trios and 41 duos) were available. The Yale 
Global Tic Severity Scale (YGTSS) was used to assess the peak tic severity (most severe 
condition of motor and vocal tic symptoms), and the degree of overall impairment. The three 
scales produce a total severity score that ranges from 0 to 100 (Leckman et al., 1989). 
Genomic DNA was isolated from buccal cells by the DNA purification kit obtained from Gentra 
(Minneapolis, USA). Genotyping of the -238 A/G (rs361525) and -308 A/G (rs1800629) SNPs 
was carried out using the C__2215707_10 and C__7514879_10 ABI TaqMan Genotyping 
Assays, respectively, on a 7300 Real-Time PCR System (Applied Biosystems, Foster City, 
USA), according to the manufacturer’s instructions.  
SPSS 17.0 for Windows (IBM Corporation, Armonk, NY, USA) 
was used for the case-control and tic severity analyses. Deviation from the Hardy-Weinberg 
equilibrium was calculated by comparing expected and observed genotypes (chi-square analyses 
with df = 1). In the family based analysis the Transmission Disequilibrium Test (TDT) was used 
to calculate allele transmission from heterozygote parents using the formula TDT χ2
 
= (b-
c)2/(b+c) where b is the number of times when heterozygous parents transmit the risk allele to an 
affected offspring and c is the number of times that they transmit the other allele (Spielman et al., 
1993). The adjusted significance level for multiple comparisons was calculated by the false 
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discovery rate (Benjamini et al., 2001). The in silico transcription factor binding analysis was 
performed using the Alibaba 2.1 transcription factor binding prediction software 
(http://www.gene-regulation.com/) and the TRANSFAC database. 
 
Results 
The genotype and allele frequencies of the two TNF promoter polymorphisms in the patient and 
control groups are presented in Table 2. No significant deviation from the Hardy-Weinberg 
equilibrium was detected in either the patient or control groups. The ADHD group served as a 
control child psychiatric sample (with possible basal ganglia involvement). Neither of the TNF 
polymorphisms were associated with ADHD or OCD, only the TS group showed higher G-allele 
frequency at the -308 A/G SNP (χ2
 
= 4.33, df = 1, p = 0.037). 
Since there was no AA homozygote at the -238 A/G (rs361525) SNP in the patient groups, the 
AA and AG genotypes were grouped together in the chi-square analyses. For the same reason, we 
could test only the recessive model at the risk calculation using the G-allele as the risk allele, and 
the AA + AG vs GG grouping system. Similarly, the odds ratio (OR) calculation at the -308 A/G 
(rs1800629) SNP was meaningful only in the AA + AG vs GG setting (see Table 2 for ORs). 
These genotype-wise analyses did not yield any significant result; we could observe only a 
tendency at the -308 A/G SNP in the TS group. 
To confirm the possible genetic association between the -308 G-allele and TS, parents of TS 
patients were genotyped for the -308 A/G SNP and the Transmission Disequilibrium Test (TDT) 
was carried out. In the available 105 TS families the allele transmission could be unambiguously 
determined at 40 heterozygote parents: the A-allele was transmitted 12 times, whereas the G-
allele was transmitted 28 times (TDT χ2
 
= 6.4, p = 0.011). The comorbid conditions, sex, and age 
of this reduced TS sample (n = 105, 87.6% male, mean age 12.17 ± 2.99, comorbid ADHD 
37.1%, OCD 24.8%, anxiety 23.8%, CD 7.6%, LD 16.2%) did not differ significantly (p > 0.1) 
from the total TS sample (n = 117). 
Next, we wanted to check if the same association would exist in a broader sense for tic disorders. 
Therefore, from our sample of 413 child psychiatric patients 186 children with tic symptoms - 
independently of the main diagnosis - were analyzed for the -308 A/G SNP (for description of 
this patient group see Table 1). With genotype frequencies of AA 1.1%, AG 19.9%, GG 79%, 
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and allele frequencies of A 11%, G 89% among the children with tic symptoms, the case-control 
analyses (allele-wise: χ2
 
= 3.7, df = 1, p = 0.054, and genotype-wise (AA + AG vs GG): χ2
 
= 2.6, 
df = 1, p = 0.107) showed similar tendencies. The family analysis showed preferential 
transmission of the -308 G-allele in the available 155 families of children with tic symptoms (34 
times transmission vs 19 times non-transmission, TDT χ2
 
= 4.25, p = 0.039). Using the Yale 
Global Tic Severity Scale (YGTSS) scores, however, the GG genotype group did not have 
significantly more severe tic symptoms compared to the AG genotype group using either the 
specific or the overall tic severity scores in the analysis of variance (motor tic: AG 12.63 ± 4.74 
vs GG 13.90 ± 4.98, p = 0.235; vocal tic: AG 9.96 ± 5.89 vs GG 10.07 ± 5.96, p = 0.935; 
impairment: AG 21.78 ± 8.90 vs GG 23.43 ± 11.13, p = 0.478; total score: AG 45.11 ± 17.39 vs 
GG 47.38 ± 20.46, p = 0.599). 
Since the TS and tic symptom present groups were overlapping, we set the number of analyses to 
four in this sample (corresponding to the association analyses of -238 A/G SNP & TS, -308 A/G 
SNP & TS, -308 A/G SNP & tic symptom present group, and -308 A/G SNP & tic symptom 
severity scores) at the multiple testing correction with the false discovery rate. With the adjusted 
significance level at α = 0.05, only the TS family based association result stayed significant (p ˂ 
0.0125). Taken together, these findings indicate a potential association of the TNF -308 G-allele 
with TS, but not necessarily with tic symptoms.  
Finally, we performed an in silico transcription factor binding analysis using the Alibaba 2.1 
transcription factor binding prediction software and the TRANSFAC database. This analysis 
revealed that the -308 polymorphic site and its 5’ and 3’ flanking regions contain numerous and 
partly overlapping Sp1 (specificity protein 1) binding sites, and the -308 G-allele - but not the -
308 A-allele - allows binding of upstream stimulatory factors (USF) 1 and 2 to the promoter. 
USFs are known to elicit transcriptional activation via binding to E-box sequences in promoters; 
therefore, the presence of the G-allele can contribute to higher transcriptional activity.  
Discussion  
Research on the possible roles of certain inflammatory cytokines in the background of 
neuropsychiatric disorders has been a growing field of neuroscience. Several studies established 
associations between plasma cytokine levels and OCD (Fontenelle et al., 2012), autism spectrum 
disorder (Ricci et al., 2013), or depressive disorder (Raedler, 2011). Although little is known on 
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the penetration of plasma cytokines through the blood-brain-barrier, the presence of cytokine 
producing macrophages (i.e. microglial cells) in the central nervous system confers 
pathophysiological relevance on this issue (Sarit et al., 2012). Schizophrenia has been found to 
associate with many cytokines to such extent, that even anti-inflammatory medications have been 
proposed to combat or prevent this devastating mental illness (Mansur et al., 2012). Similarly, the 
mutual relationship between depression and plasma levels of inflammatory modulators has 
extensively been investigated (Fagundes et al., 2013; Cilan et al., 2012). 
To address the possible involvement of autoimmune processes in TS and OCD, we analyzed TNF 
polymorphisms. The ADHD group served as a basal ganglia related but not PANDAS connected 
patient group. As expected, there was no association between TNF polymorphisms and ADHD. 
On the other hand, the positive association between TNF -308 A/G SNP and TS suggests a 
functional significance of TNF in this disorder, which – to our best knowledge – has not been 
reported yet. Although a similar study has been conducted in a Chinese Han population, no 
association was reported between the TNF -238 A/G polymorphism and TS (Liu et al., 2011), 
and – unfortunately – the -308 A/G SNP was not investigated. 
Concerning the genetic analyses in OCD, our negative findings support the results of Zai et al., 
(2006), but contradict the findings of Lüleyap et al., (2012) and Hounie et al., (2008). The latter 
workgroup reported associations between OCD and both TNF -308 (rs1800629) A/G and -238 
(rs361525) A/G SNP in a Brazilian population (Hounie et al., 2008). Association of the -238 A-
allele with OCD has also been confirmed by Cappi et al., (2012) using an extended patient 
population (the number of OCD cases increased from 111 to 183), whereas the association 
between the -308 A-allele and OCD has not been verified. The -308 A-allele and AA genotype, 
however, was much more frequent among 45 OCD patients compared to 58 controls in a Turkish 
study (Lüleyap et al., 2012). One of the possible reasons behind the contradictory findings could 
be the different allele frequencies in the studied populations: the frequency of the minor -308 A-
allele was much lower in the Turkish and Brazilian control groups (4.3% and 9%, respectively) 
compared to Caucasian populations (see the CEU panel with 17.3% 
(http://www.ncbi.nlm.nih.gov/snp/), the Hungarian control sample with 15.2% (Table 2), or the 
mainly Caucasian Canadian sample with 13.2% (Zai et al., 2006)). 
The -308 A/G SNP (rs1800629) is considered a functional polymorphism as Wilson et al. (1997) 
revealed a DNase I hypersensitivity site at the -308 locus, however, the putative transcription 
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factor binding here has not been identified yet. We performed an in silico transcription factor 
binding analysis which showed that the -308 G-allele enables binding of upstream stimulatory 
factors 1 and 2 to the promoter. It is tempting to speculate that the -308 G-allele is able to recruit 
USF, resulting in higher TNF transcription activity and higher cytokine levels; therefore, it can be 
a risk factor for basal ganglia impairment. 
Given that the -308 A/G SNP is highly associated with inflammatory diseases such as atopic 
dermatitis (Behniafard et al., 2012), Graves’ disease (Kammoun-Krichen et al., 2008) and 
bronchial asthma (Witte et al., 2002), several attempts have been made in the past two decades to 
assign functional significance to this polymorphism. Results from numerous reporter vector 
based transient transfection assays revealed that the -308 A-allele confers higher transcriptional 
activity on the TNF promoter. Kroeger et al. (1997) found that the -308 A-allele (previously 
termed TNF2 allele) exhibited twofold transcriptional activation in phorbol ester activated Jurkat 
cells. Essentially identical results have been published by Wilson et al. (1997), and their findings 
have been corroborated by Sallakci and co-workers (2005), who performed an ELISPOT analysis 
to demonstrate that the A-allele produced higher TNF expression levels. Baseggio et al. (2004) 
found a protein complex associating only with the -308 A-allele in electrophoretic mobility shift 
assays but failed to identify it. However, there are equal amount of negative reports observing no 
differences in the transcriptional activity of these TNF alleles (Brinkman et al., 1995-1996; 
Uglialoro et al., 1998; Stuber et al., 1995-1996), therefore the functionality of the -308 A/G SNP 
remains an open question. 
In conclusion, our results show no association between TNF promoter polymorphisms and OCD 
in a Caucasian population. However, we report an association of the TNF -308 A/G SNP 
(rs1800629) with Tourette syndrome. This finding might assign a specific neuromodulatory role 
to this seminal inflammatory cytokine in TS among basal ganglia based neuropsychiatric 
disorders. However, a major drawback of our study is that we did not measure anti-streptococcal 
antibody titers in patients that prevented us from discriminating between PANDAS and non-
PANDAS samples in our TS population. Therefore, this study should be replicated accordingly. 
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Table 1. Clinical description of the patient groups 
 
      ADHD 
    (n = 194) 
      OCD 
   (n = 102)  
       TS 
   (n = 117) 
       patients  
with tic (n = 186) 
age 9.41 ± 2.69 15.12 ± 4.19 12.60 ± 3.83 12.46 ± 4.16 
sex 88.1% male 69.6% male 88.9% male 86% male 
secondary diagnoses comorbidity 
ADHD  14 (13.7%) 44 (37.6%) 89 (47.8%) 
OCD 0  32 (27.4%) 60 (32.3%) 
tic disorder 42 (21.6%) 28 (27.5%)   
anxiety 29 (14.9%) 47 (46.1%) 30 (25.6%) 53 (28.5%) 
conduct disorder 63 (32.5%) 8 (7.8%) 12 (10.3%) 26 (14.0%) 
learning disorder 54 (27.8%) 8 (7.8%) 18 (15.4%) 33 (17.7%) 
 
 
Table 2. Genotype and allele frequencies of TNF polymorphisms in patient and control 
groups 
 
polymorphism control ADHD OCD TS 
-238 A/G (rs361525) 
AA 2 (0.5%) 0 0 0 
AG 42 (10.4%) 19 (9.8%) 10 (9.8%) 13 (11.1%) 
GG 361 (89.1%) 175 (90.2%) 92 (90.2%) 104 (88.9%) 
genotype-wise chi-square p a 0.689 0.756 0.940 
OR (95% CI) in the recessive 







A 5.7% 4.9% 4.9% 5.6% 
G 94.3% 95.1% 95.1% 94.4% 
allele-wise chi-square p 0.576 0.664 0.943 
-308 A/G (rs1800629) 
AA 13 (3.2%) 9 (4.6%) 3 (2.9%) 0 
AG 97 (24.0%) 48 (24.7%) 28 (27.5%) 23 (19.7%) 
GG 295 (72.8%) 137 (70.6%) 71 (69.6%) 94 (80.3%) 
genotype-wise chi-square p 0.653 0.763 b 0.075 b 
OR (95% CI) in the recessive 







A 15.2% 17.0% 16.7% 9.8% 
G 84.8% 83.0% 83.3% 90.2% 
allele-wise chi-square p 0.417 0.601 0.037 
 
a
 At the -238 A/G (rs361525) SNP the AA genotypes were grouped together with AG genotypes 
in order to have the expected count more than 5 in every cell in the chi-square test.  
b
 One cell (17%) has the expected count less than 5 in the chi-square test. 
 
